Schwind eye tech solutions

Named after its founder, the enterprise was registered in 1958 as Herbert Schwind GmbH & Co. KG in the Aschaffenburg trade register. The company initially positioned itself as a full service provider and diagnostic supplier for ophthalmologists.

Founded in 1964, the subsidiary Titmus Eurocon was created, to specialize in the development of contact lenses. In 1972, with the introduction of the first soft contact lenses, Titmus Eurocon brought a world novelty to the market. Titmus Eurocon was sold in 1982 to the Swiss group Ciba Geigy (Novartis).

In the early the 1990s, Schwind expanded its focus by adding a second area of expertise to its portfolio: the development, production, and distribution of eye lasers for vision correction, including refractive and therapeutic corneal surgery. In 1992 the first treatment of myopia with a shrink laser took place in South Korea. Seven years following this event, in 1999, the company management withdrew Schwind from the business field in service provision for ophthalmologists to specialise solely in the field of eye laser correction. At the same time, they changed their name to Schwind eye-tech-solutions.

In 2007 the company introduced a new excimer laser generation, the Schwind Amaris, which is the first and only laser system worldwide to combine all available modern refractive technologies in one system. Since then, the Schwind Amaris product family has been enhanced continuously. Today, Schwind Amaris laser systems compete successfully in a market otherwise dominated by multinational, market-listed corporations. The latest Amaris evolution features, with 1050 Hertz, the second after Optosystems Microscan (1100 Hertz) the highest available pulse repetition rate on the market of excimer lasers today.

In 2016 international private investment firm, ARDIAN, purchased a 70% stake in the company.

In 2021, Global law firm, White and Case LLP advised international private investment firm ARDIAN on the sale of Schwind to private equity company Adagia Partners. The details of the transaction were not disclosed by the parties. In December 2021, Adagia Partners completed the deal, purchasing the majority of the shares while Rolf Schwind retained a minority stake and agreement to continue in the role of CEO until the end of 2022.

Schwind Esiris excimer laser

Source:

Schwind Amaris excimer laser

Source:

The Schwind Amaris laser operates at 500 pulses per second and is the first laser to use two energy levels for corneal tissue removal. Approximately 80% of the tissue is removed with high energy to speed up treatment, while the remaining tissue is removed with low energy for increased precision. This method allows for the correction of a diopter in under 2.5 seconds, reducing treatment time, particularly for patients with high levels of vision defects.

The laser is equipped with an eye tracking system that monitors eye movements 1050 times per second, adjusting the laser to ensure accuracy. At the time, it was the first laser to use a five-dimensional eye tracker, compensating for both linear and rotational eye movements during the procedure. Clinical studies indicate that patients treated with this laser achieve higher visual performance than with glasses or contact lenses, with some achieving 125% visual acuity. The Bellevue Eye Clinic in Kiel was one of the first clinics in Germany to use the laser in routine care.